Replies to post #282723 on Amarin Corp Plc (AMRN)

[Bill B]

Never forget that Mighty Casey struck out.

[Biobillionair]

Swinging for the fences is always an option and I’m not faulting those investors that want to chance a $100bn + US Vascepa market....but I WILL find fault with Amarin management if they do so, I PROMISE!

BB

[NickHous]

Yep, bring Singer (Kirk Gibson) in off the bench and make history! Or, Generic/Du-fus (Buckner) is at first base, just hit a grounder (logic/law/proper ruling) to them and watch them lose the game and series. We need AMRN/JT (Hershiser/Kershaw) throwing strikes in the mean time to the EU/ROW and rollout. Put Rick Monday in at center field to save that American flag (justice). Need get rid of these generics (Astos/Ignorant Judges) and their sign stealing (skinny label shenanigans/this whole Hatch-Waxman BS) and stop this thievery for the goodness of the game (the whole FDA/USPTO/Drug development process)

Dodgers fan here. Always see Buckner as a Dodger and Gibson as a Detroit Tiger and Monday as a Cub, but they once wore Dodger blue!

Ok, I think I'm ready for baseball again!

[couldbebetter]

AMRN will lay a great Cardiovascular medication to waste if it
continues with the misguided strategy of GIA! Vascepa should be one
of the most used medications of all time, but only if it is placed
in the hands of BP! Adam Feuerstein warned that AMRN was playing
on Cardiovascular turf...and that JT could become a "Wall Street Hero"
if he were to sell AMRN to BP. Did JT ever receive any credible BO
offers? (Rumours were that offers were made and that JT may have
decided they were inadequate.) Perhaps JT truly believed AMRN was
worth far more than any BP was willing to pay. Vascepa is still a
great drug...and may be very valuable if it is in the right hands.
If Vascepa is left in the wrong hands, it runs the risk of being
"laid to waste." If JNJ owned Vascepa there would be speculation
of Vascepa's potential to ameleorate residual inflammation as a
result of COVID-19. How ironic that not only may the full potential
of Vascepa to treat CVD might be missed...but also its potential
to help heal from the ravages of COVID-19 as well.